Due to the COVID-19 crisis, the information below is subject to change,
in particular that concerning the teaching mode (presential, distance or in a comodal or hybrid format).
3 credits
30.0 h + 15.0 h
Q2
Teacher(s)
Dessy Chantal; Duhoux Francois; Duhoux Francois (compensates Hermans Emmanuel); Dujardin Nathalie; Hermans Emmanuel; Spinewine Anne (coordinator); Wertz Aline; Wertz Aline (compensates Hermans Emmanuel);
Language
French
Main themes
Upon completion of this course, the pharmacist should be able to:
- explain the pharmacokinetic and pharmacodynamic factors that need to be taken into account in these specific populations, when prescribing medicines
- explain the indications and contra-indications specific to each population
- understand and to manage drug interactions in these populations
- evaluate the adequacy of drug dosages
- provide appropriate counselling to patients and carers relative to their drug regimen
- discuss with other health care professionals the rational use of medicines in these specific populations
- summarise and critically appraise a published paper relative to a clinical trial relative to pharmacotherapy in the abovementioned populations.
- explain the pharmacokinetic and pharmacodynamic factors that need to be taken into account in these specific populations, when prescribing medicines
- explain the indications and contra-indications specific to each population
- understand and to manage drug interactions in these populations
- evaluate the adequacy of drug dosages
- provide appropriate counselling to patients and carers relative to their drug regimen
- discuss with other health care professionals the rational use of medicines in these specific populations
- summarise and critically appraise a published paper relative to a clinical trial relative to pharmacotherapy in the abovementioned populations.
Aims
At the end of this learning unit, the student is able to : | |
| 1 |
To acquire knowledge and skills in the pharmaceutical care of specific populations, including infants and children, elderly people, pregnant women, and drug abusers. |
Content
- Pharmacotherapy for several specific populations/situations, namely: pregnant and breastfeeding women; chilfren; older people; persons with cancer
- For each opulation/situation: general considerations related to medicines use in these populations/situations; baprinciples in rational medicines use; pharmacotherapy for several diseases/medical problems specific to these populations; role of the pharmacist in optimising medicines use
- For each opulation/situation: general considerations related to medicines use in these populations/situations; baprinciples in rational medicines use; pharmacotherapy for several diseases/medical problems specific to these populations; role of the pharmacist in optimising medicines use
Teaching methods
Due to the COVID-19 crisis, the information in this section is particularly likely to change.
This course includes a mixed approach including interactive lectures, some homework (e-learning), and presentation of an assignment (journal club). Teachers – pharmacists and physicians with academic/clinical experience - pay special attention to making links between theory and practice and illustrate with clinical vignettes, where the role of pharmacists in optimising medicines use is highlighted.
Evaluation methods
Due to the COVID-19 crisis, the information in this section is particularly likely to change.
1° written examination with questions to evaluate knowledge and skills (ie theory and practice-based questions)2° oral presentation of a journal club relative to a paper relative to a specific aspect of pharmacotherapy in a specific population addressed in the present course.
Teaching materials
- aucun support obligatoire
Faculty or entity
FARM
